Clinical Trials
7 trialsNCT07362602 2026-01-23
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Phase EARLY_PHASE1 Not yet recruiting
NCT07362732 2026-01-23
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
Sichuan University
Phase EARLY_PHASE1 Not yet recruiting
NCT07358195 2026-01-22
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Massachusetts General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07117175 2025-08-12
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT06837389 2025-02-20
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT04662788 2020-12-10
Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT04657965 2020-12-08
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting